Cargando…

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity

BACKGROUND: We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly diagnosed, untreated JDM. FINDINGS: We enroll...

Descripción completa

Detalles Bibliográficos
Autores principales: Pachman, Lauren M., Morgan, Gabrielle, Klein-Gitelman, Marisa S., Ahsan, Najah, Khojah, Amer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571265/
https://www.ncbi.nlm.nih.gov/pubmed/37828536
http://dx.doi.org/10.1186/s12969-023-00903-x
_version_ 1785119950144274432
author Pachman, Lauren M.
Morgan, Gabrielle
Klein-Gitelman, Marisa S.
Ahsan, Najah
Khojah, Amer
author_facet Pachman, Lauren M.
Morgan, Gabrielle
Klein-Gitelman, Marisa S.
Ahsan, Najah
Khojah, Amer
author_sort Pachman, Lauren M.
collection PubMed
description BACKGROUND: We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly diagnosed, untreated JDM. FINDINGS: We enrolled 140 untreated JDM and 46 age, race and sex matched healthy controls, ages 2–17. We selected items from the Juvenile Myositis Registry for analysis. Variables include average ERL density of 8 fingers, average capillary pattern, hemorrhages, and clinical and laboratory correlates. Laboratory data includes Myositis Specific Antibodies (MSA), disease activity scores (DAS), Childhood Myositis Assessment Scale (CMAS), and standard clinical serologic data. The reduced mean ERL density is 5.1 ± 1.5/mm for untreated JDM vs 7.9 ± 0.9/mm for healthy controls, p < 0.0001, and is associated with DAS-skin, r = -0.27 p = 0.014, which did not change within the age range tested. Untreated JDM with MSA Tif-1-γ had the lowest ERL density, (p = 0.037); their ERL patterns were primarily “open” and the presence of hemorrhages in the nailfold matrix was associated with dysphagia (p = 0.004). CONCLUSIONS: Decreased JDM ERL density is associated with increased clinical symptoms; nailfold hemorrhages are associated with dysphagia. Duration of untreated disease symptoms and MSA, modify NFC shape. We speculate nailfold characteristics are useful indicators of disease activity in children with JDM before start of therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00903-x.
format Online
Article
Text
id pubmed-10571265
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105712652023-10-14 Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity Pachman, Lauren M. Morgan, Gabrielle Klein-Gitelman, Marisa S. Ahsan, Najah Khojah, Amer Pediatr Rheumatol Online J Short Report BACKGROUND: We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly diagnosed, untreated JDM. FINDINGS: We enrolled 140 untreated JDM and 46 age, race and sex matched healthy controls, ages 2–17. We selected items from the Juvenile Myositis Registry for analysis. Variables include average ERL density of 8 fingers, average capillary pattern, hemorrhages, and clinical and laboratory correlates. Laboratory data includes Myositis Specific Antibodies (MSA), disease activity scores (DAS), Childhood Myositis Assessment Scale (CMAS), and standard clinical serologic data. The reduced mean ERL density is 5.1 ± 1.5/mm for untreated JDM vs 7.9 ± 0.9/mm for healthy controls, p < 0.0001, and is associated with DAS-skin, r = -0.27 p = 0.014, which did not change within the age range tested. Untreated JDM with MSA Tif-1-γ had the lowest ERL density, (p = 0.037); their ERL patterns were primarily “open” and the presence of hemorrhages in the nailfold matrix was associated with dysphagia (p = 0.004). CONCLUSIONS: Decreased JDM ERL density is associated with increased clinical symptoms; nailfold hemorrhages are associated with dysphagia. Duration of untreated disease symptoms and MSA, modify NFC shape. We speculate nailfold characteristics are useful indicators of disease activity in children with JDM before start of therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00903-x. BioMed Central 2023-10-13 /pmc/articles/PMC10571265/ /pubmed/37828536 http://dx.doi.org/10.1186/s12969-023-00903-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Short Report
Pachman, Lauren M.
Morgan, Gabrielle
Klein-Gitelman, Marisa S.
Ahsan, Najah
Khojah, Amer
Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title_full Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title_fullStr Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title_full_unstemmed Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title_short Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
title_sort nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571265/
https://www.ncbi.nlm.nih.gov/pubmed/37828536
http://dx.doi.org/10.1186/s12969-023-00903-x
work_keys_str_mv AT pachmanlaurenm nailfoldcapillarydensityin140untreatedchildrenwithjuveniledermatomyositisanindicatorofdiseaseactivity
AT morgangabrielle nailfoldcapillarydensityin140untreatedchildrenwithjuveniledermatomyositisanindicatorofdiseaseactivity
AT kleingitelmanmarisas nailfoldcapillarydensityin140untreatedchildrenwithjuveniledermatomyositisanindicatorofdiseaseactivity
AT ahsannajah nailfoldcapillarydensityin140untreatedchildrenwithjuveniledermatomyositisanindicatorofdiseaseactivity
AT khojahamer nailfoldcapillarydensityin140untreatedchildrenwithjuveniledermatomyositisanindicatorofdiseaseactivity